Companies
-
Takeda adds firepower to patient advocacy
- Mon Aug 31
Public Affairs boss Paula Dry has picked a familiar face to lead patient advocacy in Takeda’s growing Oceania Public Affairs team.
Read more -
First targeted lupus treatment fast-tracked to PBS
- Mon Aug 31
PBS funds the first targeted treatment for lupus‑related kidney disease after the PBAC offered Roche a fast-tracked pricing pathway.
Read more -
Sanofi Global Vaccines Head in Sydney
- Mon Aug 31
Dr Jean‑François Toussaint will participate as an expert coach at the Australian Vaccine and Value Chain Conference held in Sydney this week.
Read more -
Astellas names new Australia GM
- Fri Aug 28
Five months after its former Australia GM left, Astellas has named a familiar face as the incoming head of its Australian business.
Read more -
Lilly ANZ policy head leaves for mental health gig
- Wed Aug 26
After an impressive stint in pharma that saw Lilly take a fresh approach to media and access, Katherine Burchfield has left to lead a mental health service.
Read more -
Who’s looking for a Country Manager?
- Wed Aug 26
Another company has commenced the hunt for a new Country Manager. Given its ongoing struggle for reimbursement, it may prove a tough gig.
Read more -
Aussie patients wait for homegrown therapy
- Wed Aug 26
Europe secures access to the first and only approved Rett syndrome treatment joining the US and Canada, but there’s no sign of a TGA dossier.
Read more -
PBAC doubles-down on its value demands
- Mon Aug 24
PBAC recommended two out of three submissions, its decision-making demonstrating how even with high unmet need, price is what matters most.
Read more